Fri, 11 Apr 2014 | ADMINISTRATION
Screensafe UK Limited, Trimega Laboratories Limited and Ingemino Testing Services Limited have all entered administration.
Paul Flint and Brian Green from KPMG’s restructuring practice were appointed joint administrators to the trio of companies – that specialise in drug, alcohol and paternity testing – on 7 April.
Screensafe, based in Stafford, provides drug and alcohol tests for the workplace. The administrators have already sold the business along with some assets to Synergy Health Laboratory Services Limited. As part of the sale, 16 members of staff were also transferred to new owner.
Trimega Laboratories, meanwhile, operated out of Blackley in Great Manchester and provided legally defensible testing to be used in decisions for child protection cases. Its tests included hair drug, alcohol and steroid testing, as well as DNA tests.
Ingemino Testing, which is also based in Blackley, was a laboratory company that provided the facilities for the aforementioned two testing companies.
A sale is being sought for the assets of Trimega Laboratories and Ingemino Testing. Trading has been stopped and 49 staff from the two companies have lost their jobs.
Paul Flint, associate partner at KPMG and joint administrator, said: “The paternity testing market has declined as a result of recent changes to the legal aid system.
“Despite marketing the Trimega Laboratories and Ingemino Testing Services business as going concerns prior to our appointment, a buyer could not be found and unfortunately, a total of 49 redundancies have been made across these two businesses in Blackley.”
_______________________________________________________________________
Related information:
Contact the administrator to ask about the assets
Funding your acquisition
This is a unique opportunity to acquire two well-established B2B companies operating across multiple sectors throughout the UK, boasting strong client relationships and secure contracted revenues poised for further expansion.
LEASEHOLD
This is a unique opportunity to acquire a prominent company in a specialist sector with a high barrier to entry, offering integration potential and a cash-generative model with repeat revenue.
This business presents an enticing opportunity with established relationships with blue-chip organisations globally, a strong client retention rate, and the potential for relocation.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.